T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis

European Journal of Immunology

Volumn 46, Issue 2, 2016, Pages 281-290

  Blanco, Patrick ^a,b,c   Ueno, Hideki ^d   Schmitt, Nathalie ^d  

^a CNRS Bordeaux Segalen University   (France)

^b CNRS   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

Author keywords

Autoantibody; B cell; Systemic lupus erythematosus (SLE); Tfh cell

Indexed keywords

ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELL ACTIVATION; DENDRITIC CELL; DISEASE COURSE; HELPER CELL; HUMAN; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; NOTE; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T FOLLICULAR HELPER CELL; ANIMAL; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANTIGEN ANTIBODY COMPLEX; AUTOANTIBODY; NUCLEOPROTEIN;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; B-LYMPHOCYTES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; NUCLEOPROTEINS; SELF TOLERANCE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84956925010     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201545760     Document Type: Note

References (123)

1. Thin, G., On the pathology of lupus erythematosus. Med. Chir. Trans 1875. 58: 59-66 51.
2. Tsokos, G. C., Systemic lupus erythematosus. N. Engl. J. Med. 365: 2110-2121.
3. Mohan, C. and Putterman, C., Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat. Rev. Nephrol. 11: 329-341.
4. Lisnevskaia, L., Murphy, G. and Isenberg, D., Systemic lupus erythematosus. Lancet 384: 1878-1888.
5. Yurasov, S., Tiller, T., Tsuiji, M., Velinzon, K., Pascual, V., Wardemann, H. and Nussenzweig, M. C., Persistent expression of autoantibodies in SLE patients in remission. J. Exp. Med. 2006. 203: 2255-2261.
6. Yurasov, S., Wardemann, H., Hammersen, J., Tsuiji, M., Meffre, E., Pascual, V. and Nussenzweig, M. C., Defective B cell tolerance checkpoints in systemic lupus erythematosus. J. Exp. Med. 2005. 201: 703-711.
7. Tiller, T., Tsuiji, M., Yurasov, S., Velinzon, K., Nussenzweig, M. C. and Wardemann, H., Autoreactivity in human IgG+ memory B cells. Immunity 2007. 26: 205-213.
8. Tipton, C. M., Fucile, C. F., Darce, J., Chida, A., Ichikawa, T., Gregoretti, I., Schieferl, S. et al., Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat. Immunol. 2015. 16: 755-765.
9. Arce, E., Jackson, D. G., Gill, M. A., Bennett, L. B., Banchereau, J. and Pascual, V., Increased frequency of pre-germinal center b cells and plasma cell precursors in the blood of children with systemic lupus erythematosus. J. Immunol. 2001. 167: 2361-2369.
10. Jacobi, A. M., Odendahl, M., Reiter, K., Bruns, A., Burmester, G. R., Radbruch, A., Valet, G. et al., Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2003. 48: 1332-1342.
11. Victora, G. D. and Nussenzweig, M. C., Germinal centers. Annual Rev. Immunol. 2012. 30: 429-457.
12. Vinuesa, C. G. and Cyster, J. G., How T cells earn the follicular rite of passage. Immunity 2011. 35: 671-680.
13. Ma, C. S., Deenick, E. K., Batten, M. and Tangye, S. G., The origins, function, and regulation of T follicular helper cells. J. Exp. Med. 2012. 209: 1241-1253.
14. Crotty, S., T follicular helper cell differentiation, function, and roles in disease. Immunity 2014. 41: 529-542.
15. Ueno, H., Banchereau, J. and Vinuesa, C. G., Pathophysiology of T follicular helper cells in humans and mice. Nat. Immunol. 2015. 16: 142-152.
16. Ueno, H., Schmitt, N., Klechevsky, E., Pedroza-Gonzalez, A., Matsui, T., Zurawski, G., Oh, S. et al., Harnessing human dendritic cell subsets for medicine. Immunol. Rev. 2010. 234: 199-212.
17. Deng, Y. and Tsao, B. P., Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat. Rev. Rheumatol. 2010. 6: 683-692.
18. Blanco, P., Palucka, A. K., Pascual, V. and Banchereau, J., Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008. 19: 41-52.
19. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. and Banchereau, J., Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001. 294: 1540-1543.
20. Ganguly, D., Haak, S., Sisirak, V. and Reizis, B., The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 2013. 13: 566-577.
21. Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J. and Pascual, V., Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J. Exp. Med. 2003. 197: 711-723.
22. Elkon, K. B. and Wiedeman, A., Type I IFN system in the development and manifestations of SLE. Curr. Opin. Rheumatol. 2012. 24: 499-505.
23. Sisirak, V., Ganguly, D., Lewis, K. L., Couillault, C., Tanaka, L., Bolland, S., D'Agati, V. et al., Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J. Exp. Med. 2014. 211: 1969-1976.
24. Bave, U., Alm, G. V. and Ronnblom, L., The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J. Immunol. 2000. 165: 3519-3526.
25. Batteux, F., Palmer, P., Daeron, M., Weill, B. and Lebon, P., FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus. Eur. Cytokine Netw. 1999. 10: 509-514.
26. Ronnblom, L. and Alm, G. V., Systemic lupus erythematosus and the type I interferon system. Arthritis Res. Ther. 2003. 5: 68-75.
27. Barrat, F. J. and Coffman, R. L., Development of TLR inhibitors for the treatment of autoimmune diseases. Immunol. Rev. 2008. 223: 271-283.
28. Saito, K., Kukita, K., Kutomi, G., Okuya, K., Asanuma, H., Tabeya, T., Naishiro, Y. et al., Heat shock protein 90 associates with Toll-like receptors 7/9 and mediates self-nucleic acid recognition in SLE. Eur. J. Immunol. 2015. 45: 2028-2041.
29. Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M. et al., Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3: 73ra20.
30. Duffau, P., Seneschal, J., Nicco, C., Richez, C., Lazaro, E., Douchet, I., Bordes, C. et al., Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci. Transl. Med. 2: 47ra63.
31. Hagberg, N., Berggren, O., Leonard, D., Weber, G., Bryceson, Y. T., Alm, G. V., Eloranta, M. L. et al., IFN-alpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1beta and LFA-1. J. Immunol. 186: 5085-5094.
32. Ding, D., Mehta, H., McCune, W. J. and Kaplan, M. J., Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 2006. 177: 5878-5889.
33. Crispin, J. C., Vargas-Rojas, M. I., Monsivais-Urenda, A. and Alcocer-Varela, J., Phenotype and function of dendritic cells of patients with systemic lupus erythematosus. Clin. Immunol. 2012. 143: 45-50.
34. Decker, P., Kotter, I., Klein, R., Berner, B. and Rammensee, H. G., Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006. 45: 1087-1095.
35. Bondanza, A., Zimmermann, V. S., Dell'Antonio, G., Dal Cin, E., Capobianco, A., Sabbadini, M. G., Manfredi, A. A. et al., Cutting edge: dissociation between autoimmune response and clinical disease after vaccination with dendritic cells. J. Immunol. 2003. 170: 24-27.
36. Kim, S. J., Zou, Y. R., Goldstein, J., Reizis, B. and Diamond, B., Tolerogenic function of Blimp-1 in dendritic cells. J. Exp. Med. 2011. 208: 2193-2199.
37. Jego, G., Palucka, A. K., Blanck, J. P., Chalouni, C., Pascual, V. and Banchereau, J., Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity 2003. 19: 225-234.
38. Vincent, F. B., Morand, E. F., Schneider, P. and Mackay, F., The BAFF/APRIL system in SLE pathogenesis. Nat. Rev. Rheumatol. 10: 365-373.
39. Joo, H., Coquery, C., Xue, Y., Gayet, I., Dillon, S. R., Punaro, M., Zurawski, G. et al., Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation. J. Exp. Med. 2012. 209: 1335-1348.
40. Bentebibel, S. E., Schmitt, N., Banchereau, J. and Ueno, H., Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc. Natl. Acad. Sci. USA 2011. 108: E488-E497.
41. Shulman, Z., Gitlin, A. D., Targ, S., Jankovic, M., Pasqual, G., Nussenzweig, M. C. and Victora, G. D., T follicular helper cell dynamics in germinal centers. Science 2013. 341: 673-677.
42. Nurieva, R. I., Chung, Y., Hwang, D., Yang, X. O., Kang, H. S., Ma, L., Wang, Y. H. et al., Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008. 29: 138-149.
43. Bossaller, L., Burger, J., Draeger, R., Grimbacher, B., Knoth, R., Plebani, A., Durandy, A. et al., ICOS deficiency is associated with a severe reduction of CXCR5+CD4 germinal center Th cells. J. Immunol. 2006. 177: 4927-4932.
44. Hamel, K. M., Cao, Y., Wang, Y., Rodeghero, R., Kobezda, T., Chen, L. and Finnegan, A., B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis. Eur. J. Immunol. 2010. 40: 3117-3127.
45. Good-Jacobson, K. L., Szumilas, C. G., Chen, L., Sharpe, A. H., Tomayko, M. M. and Shlomchik, M. J., PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat. Immunol. 2010. 11: 535-542.
46. Bryant, V. L., Ma, C. S., Avery, D. T., Li, Y., Good, K. L., Corcoran, L. M., de Waal Malefyt, R. et al., Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J. Immunol. 2007. 179: 8180-8190.
47. Chtanova, T., Tangye, S. G., Newton, R., Frank, N., Hodge, M. R., Rolph, M. S. and Mackay, C. R., T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J. Immunol. 2004. 173: 68-78.
48. Bentebibel, S.-E., Schmitt, N., Banchereau, J. and Ueno, H., Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc. Natl. Acad. Sci. USA 2011. 10.1073/pnas.1100898108.
49. Spolski, R. and Leonard, W. J., Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 2008. 26: 57-79.
50. Linterman, M. A., Beaton, L., Yu, D., Ramiscal, R. R., Srivastava, M., Hogan, J. J., Verma, N. K. et al., IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J. Exp. Med. 2010. 207: 353-363.
51. Zotos, D., Coquet, J. M., Zhang, Y., Light, A., D'Costa, K., Kallies, A., Corcoran, L. M. et al., IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J. Exp. Med. 2010. 207: 365-378.
52. MacLennan, I. C., Toellner, K. M., Cunningham, A. F., Serre, K., Sze, D. M., Zuniga, E., Cook, M. C. et al., Extrafollicular antibody responses. Immunol. Rev. 2003. 194: 8-18.
53. Lee, S. K., Rigby, R. J., Zotos, D., Tsai, L. M., Kawamoto, S., Marshall, J. L., Ramiscal, R. R. et al., B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells. J. Exp. Med. 2011. 208: 1377-1388.
54. Victora, G. D., Schwickert, T. A., Fooksman, D. R., Kamphorst, A. O., Meyer-Hermann, M., Dustin, M. L. and Nussenzweig, M. C., Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter. Cell 2010. 143: 592-605.
55. Vinuesa, C. G., Cook, M. C., Angelucci, C., Athanasopoulos, V., Rui, L., Hill, K. M., Yu, D. et al., A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 2005. 435: 452-458.
56. Vogel, K. U., Edelmann, S. L., Jeltsch, K. M., Bertossi, A., Heger, K., Heinz, G. A., Zoller, J. et al., Roquin paralogs 1 and 2 redundantly repress the Icos and Ox40 costimulator mRNAs and control follicular helper T cell differentiation. Immunity 2013. 38: 655-668.
57. Pratama, A., Ramiscal, R. R., Silva, D. G., Das, S. K., Athanasopoulos, V., Fitch, J., Botelho, N. K. et al., Roquin-2 shares functions with its paralog Roquin-1 in the repression of mRNAs controlling T follicular helper cells and systemic inflammation. Immunity 2013. 38: 669-680.
58. Yu, D., Tan, A. H., Hu, X., Athanasopoulos, V., Simpson, N., Silva, D. G., Hutloff, A. et al., Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature 2007. 450: 299-303.
59. Rasheed, A. U., Rahn, H. P., Sallusto, F., Lipp, M. and Muller, G., Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur. J. Immunol. 2006. 36: 1892-1903.
60. Linterman, M. A., Rigby, R. J., Wong, R. K., Yu, D., Brink, R., Cannons, J. L., Schwartzberg, P. L. et al., Follicular helper T cells are required for systemic autoimmunity. J. Exp. Med. 2009. 206: 561-576.
61. Odegard, J. M., Marks, B. R., DiPlacido, L. D., Poholek, A. C., Kono, D. H., Dong, C., Flavell, R. A. et al., ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J. Exp. Med. 2008. 205: 2873-2886.
62. Liarski, V. M., Kaverina, N., Chang, A., Brandt, D., Yanez, D., Talasnik, L., Carlesso, G. et al., Cell distance mapping identifies functional T follicular helper cells in inflamed human renal tissue. Sci. Transl. Med. 2014. 6: 230ra246.
63. Schmitt, N., Bentebibel, S. E. and Ueno, H., Phenotype and functions of memory Tfh cells in human blood. Trends Immunol. 2014. 35: 436-442.
64. Morita, R., Schmitt, N., Bentebibel, S. E., Ranganathan, R., Bourdery, L., Zurawski, G., Foucat, E. et al., Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011. 34: 108-121.
65. Le Coz, C., Joublin, A., Pasquali, J. L., Korganow, A. S., Dumortier, H. and Monneaux, F., Circulating TFH subset distribution is strongly affected in lupus patients with an active disease. PLoS One 2013. 8: e75319.
66. Choi, J. Y., Ho, J. H., Pasoto, S. G., Bunin, V., Kim, S. T., Carrasco, S., Borba, E. F. et al., Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 2015. 67: 988-999.
67. Li, X. Y., Wu, Z. B., Ding, J., Zheng, Z. H., Li, X. Y., Chen, L. N. and Zhu, P., Role of the frequency of blood CD4(+) CXCR5(+) CCR6(+) T cells in autoimmunity in patients with Sjogren's syndrome. Biochem. Biophys. Res. Commun. 2012. 422: 238-244.
68. Arroyo-Villa, I., Bautista-Caro, M. B., Balsa, A., Aguado-Acin, P., Bonilla-Hernan, M. G., Plasencia, C., Villalba, A. et al., Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis. Arthritis Res. Ther. 2014. 16: 500.
69. Romme Christensen, J., Bornsen, L., Ratzer, R., Piehl, F., Khademi, M., Olsson, T., Sorensen, P. S. et al., Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression. PLoS One 2013. 8: e57820.
70. He, J., Tsai, L. M., Leong, Y. A., Hu, X., Ma, C. S., Chevalier, N., Sun, X. et al., Circulating precursor CCR7(lo)PD-1(hi) CXCR5(+) CD4(+) T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity 2013. 39: 770-781.
71. Locci, M., Havenar-Daughton, C., Landais, E., Wu, J., Kroenke, M. A., Arlehamn, C. L., Su, L. F. et al., Human circulating PD-1(+)CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 2013. 39: 758-769.
72. Simpson, N., Gatenby, P. A., Wilson, A., Malik, S., Fulcher, D. A., Tangye, S. G., Manku, H. et al., Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010. 62: 234-244.
73. Schmitt, N., Liu, Y., Bentebibel, S. E., Munagala, I., Bourdery, L., Venuprasad, K., Banchereau, J. et al., The cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat. Immunol. 2014. 15: 856-865.
74. Schmitt, N., Bustamante, J., Bourdery, L., Bentebibel, S. E., Boisson-Dupuis, S., Hamlin, F., Tran, M. V. et al., IL-12 receptor beta1 deficiency alters in vivo T follicular helper cell response in humans. Blood 2013. 121: 3375-3385.
75. Ma, C. S., Avery, D. T., Chan, A., Batten, M., Bustamante, J., Boisson-Dupuis, S., Arkwright, P. D. et al., Functional STAT3 deficiency compromises the generation of human T follicular helper cells. Blood 2012. 119: 3997-4008.
76. Nurieva, R. I., Chung, Y., Martinez, G. J., Yang, X. O., Tanaka, S., Matskevitch, T. D., Wang, Y. H. et al., Bcl6 mediates the development of T follicular helper cells. Science 2009. 325: 1001-1005.
77. Suto, A., Kashiwakuma, D., Kagami, S., Hirose, K., Watanabe, N., Yokote, K., Saito, Y. et al., Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 2008. 205: 1369-1379.
78. Wong, C. K., Lit, L. C., Tam, L. S., Li, E. K., Wong, P. T. and Lam, C. W., Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 2008. 127: 385-393.
79. Koenig, K. F., Groeschl, I., Pesickova, S. S., Tesar, V., Eisenberger, U. and Trendelenburg, M., Serum cytokine profile in patients with active lupus nephritis. Cytokine 2012. 60: 410-416.
80. Hansel, A., Gunther, C., Baran, W., Bidier, M., Lorenz, H. M., Schmitz, M., Bachmann, M. et al., Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus. J. Autoimmun. 2013. 40: 1-8.
81. Tucci, M., Lombardi, L., Richards, H. B., Dammacco, F. and Silvestris, F., Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis. Clin. Exp. Immunol 2008. 154: 247-254.
82. Smith, S., Gabhann, J. N., Higgs, R., Stacey, K., Wahren-Herlenius, M., Espinosa, A., Totaro, M. G. et al., Enhanced interferon regulatory factor 3 binding to the interleukin-23p19 promoter correlates with enhanced interleukin-23 expression in systemic lupus erythematosus. Arthritis Rheum. 2012. 64: 1601-1609.
83. Gautier, G., Humbert, M., Deauvieau, F., Scuiller, M., Hiscott, J., Bates, E. E., Trinchieri, G. et al., A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J. Exp. Med. 2005. 201: 1435-1446.
84. Saxena, V., Lienesch, D. W., Zhou, M., Bommireddy, R., Azhar, M., Doetschman, T. and Singh, R. R., Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J. Immunol. 2008. 180: 1903-1912.
85. Okuda, S., Languino, L. R., Ruoslahti, E. and Border, W. A., Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of the mesangial extracellular matrix. J. Clin. Invest. 1990. 86: 453-462.
86. Akiba, H., Takeda, K., Kojima, Y., Usui, Y., Harada, N., Yamazaki, T., Ma, J. et al., The role of ICOS in the CXCR5+ follicular B helper T cell maintenance in vivo. J. Immunol. 2005. 175: 2340-2348.
87. Choi, Y. S., Kageyama, R., Eto, D., Escobar, T. C., Johnston, R. J., Monticelli, L., Lao, C. and Crotty, S., ICOS receptor instructs T follicular helper cell versus effector cell differentiation via induction of the transcriptional repressor Bcl6. Immunity 2011. 34: 932-946.
88. Xu, H., Li, X., Liu, D., Li, J., Zhang, X., Chen, X., Hou, S. et al., Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature 2013. 496: 523-527.
89. Teichmann, L. L., Cullen, J. L., Kashgarian, M., Dong, C., Craft, J. and Shlomchik, M. J., Local triggering of the ICOS coreceptor by CD11c(+) myeloid cells drives organ inflammation in lupus. Immunity 2015. 42: 552-565.
90. Iwai, H., Abe, M., Hirose, S., Tsushima, F., Tezuka, K., Akiba, H., Yagita, H. et al., Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis. J. Immunol. 2003. 171: 2848-2854.
91. Jacquemin, C., Schmitt, N., Contin-Bordes, C., Liu, Y., Narayanan, P., Seneschal, J., Maurouard, T. et al., OX40 ligand contributes to human lupus pathogenesis by promoting T follicular helper response. Immunity 2015. 42: 1159-1170.
92. Croft, M., Control of immunity by the TNFR-related molecule OX40 (CD134). Ann. Rev. Immunol. 2010. 28: 57-78.
93. Sawalha, A. H., Kaufman, K. M., Kelly, J. A., Adler, A. J., Aberle, T., Kilpatrick, J., Wakeland, E. K. et al., Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann. Rheum. Dis. 2008. 67: 458-461.
94. Lan, Y., Luo, B., Wang, J. L., Jiang, Y. W. and Wei, Y. S., The association of interleukin-21 polymorphisms with interleukin-21 serum levels and risk of systemic lupus erythematosus. Gene 2014. 538: 94-98.
95. Webb, R., Merrill, J. T., Kelly, J. A., Sestak, A., Kaufman, K. M., Langefeld, C. D., Ziegler, J. et al., A polymorphism within IL21R confers risk for systemic lupus erythematosus. Arthritis Rheum. 2009. 60: 2402-2407.
96. Bentham, J., Morris, D. L., Cunninghame Graham, D. S., Pinder, C. L., Tombleson, P., Behrens, T. W., Martin, J. et al., Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat. Genet. 2015. 47: 1457-1464.
97. Remmers, E. F., Plenge, R. M., Lee, A. T., Graham, R. R., Hom, G., Behrens, T. W., de Bakker, P. I. W. et al., STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. New Engl. J. Med. 2007. 357: 977-986.
98. Sigurdsson, S., Nordmark, G., Goring, H. H., Lindroos, K., Wiman, A. C., Sturfelt, G., Jonsen, A. et al., Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet. 2005. 76: 528-537.
99. Cunninghame Graham, D. S., Graham, R. R., Manku, H., Wong, A. K., Whittaker, J. C., Gaffney, P. M., Moser, K. L. et al., Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus. Nat. Genet. 2008. 40: 83-89.
100. Graham, R. R., Kozyrev, S. V., Baechler, E. C., Reddy, M. V., Plenge, R. M., Bauer, J. W., Ortmann, W. A. et al., A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat. Genet. 2006. 38: 550-555.
101. Lessard, C. J., Adrianto, I., Ice, J. A., Wiley, G. B., Kelly, J. A., Glenn, S. B., Adler, A. J. et al., Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet. 2012. 90: 648-660.
102. Hambleton, S., Salem, S., Bustamante, J., Bigley, V., Boisson-Dupuis, S., Azevedo, J., Fortin, A. et al., IRF8 mutations and human dendritic-cell immunodeficiency. N. Engl. J. Med. 2011. 365: 127-138.
103. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T. et al., IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 2011. 12: 231-238.
104. Yoshida, Y., Yoshimi, R., Yoshii, H., Kim, D., Dey, A., Xiong, H., Munasinghe, J. et al., The transcription factor IRF8 activates integrin-mediated TGF-beta signaling and promotes neuroinflammation. Immunity 2014. 40: 187-198.
105. Rodriguez-Pla, A., Patel, P., Maecker, H. T., Rossello-Urgell, J., Baldwin, N., Bennett, L., Cantrell, V. et al., IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes. J. Immunol. 2014. 192: 5586-5598.
106. Navarra, S. V., Guzman, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K. et al., Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 2011. 377: 721-731.
107. Furie, R., Nicholls, K., Cheng, T. T., Houssiau, F., Burgos-Vargas, R., Chen, S. L., Hillson, J. L. et al., Efficacy and safety of abatacept in lupus nephritis: a twelve-month, randomized, double-blind study. Arthritis Rheumatol. 2014. 66: 379-389.
108. Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O. et al., Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010. 62: 222-233.
109. Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez-Guerrero, J., Maciuca, R. et al., Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 64: 1215-1226.
110. Crispin, J. C., Kyttaris, V. C., Terhorst, C. and Tsokos, G. C., T cells as therapeutic targets in SLE. Nat. Rev. Rheumatol. 2010. 6: 317-325.
111. Sidiropoulos, P. I. and Boumpas, D. T., Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients. Lupus 2004. 13: 391-397.
112. Kalled, S. L., Cutler, A. H., Datta, S. K. and Thomas, D. W., Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 1998. 160: 2158-2165.
113. Boumpas, D. T., Furie, R., Manzi, S., Illei, G. G., Wallace, D. J., Balow, J. E. and Vaishnaw, A., A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 2003. 48: 719-727.
114. Herber, D., Brown, T. P., Liang, S., Young, D. A., Collins, M. and Dunussi-Joannopoulos, K., IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 2007. 178: 3822-3830.
115. Young, D. A., Hegen, M., Ma, H. L., Whitters, M. J., Albert, L. M., Lowe, L., Senices, M. et al., Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum. 2007. 56: 1152-1163.
116. Sakaguchi, S., Miyara, M., Costantino, C. M. and Hafler, D. A., FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010. 10: 490-500.
117. Klatzmann, D. and Abbas, A. K., The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 2015. 15: 283-294.
118. Comte, D., Karampetsou, M. P. and Tsokos, G. C., T cells as a therapeutic target in SLE. Lupus 2015. 24: 351-363.
119. von Spee-Mayer, C., Siegert, E., Abdirama, D., Rose, A., Klaus, A., Alexander, T., Enghard, P. et al., Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2015. doi: 10.1136/annrheumdis-2015-207776.
120. Ballesteros-Tato, A., Leon, B., Graf, B. A., Moquin, A., Adams, P. S., Lund, F. E. and Randall, T. D., Interleukin-2 inhibits germinal center formation by limiting T follicular helper cell differentiation. Immunity 2012. 36: 847-856.
121. Johnston, R. J., Choi, Y. S., Diamond, J. A., Yang, J. A. and Crotty, S., STAT5 is a potent negative regulator of TFH cell differentiation. J. Exp. Med. 2012. 209: 243-250.
122. Nurieva, R. I., Podd, A., Chen, Y., Alekseev, A. M., Yu, M., Qi, X., Huang, H. et al., STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function. J. Biol. Chem. 2012. 287: 11234-11239.
123. Sage, P. T. and Sharpe, A. H., T follicular regulatory cells in the regulation of B cell responses. Trends Immunol. 2015. 36: 410-418.